TR
Tejas Ramesh Zaveri
About Tejas Ramesh Zaveri
Data last updated:
Tejas Ramesh Zaveri is a Director at Dabilife Pharma Private Limited (since 2024) and Director at Nurasyl Lifesciences Private Limited (since 2024). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹53.5 Lakh; the largest is Dabilife Pharma Private Limited at ₹38.4 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dabilife Pharma Private Limited U51909MH2021PTC359801 | Director | 13 Feb 2024 | 2021 | ₹38.4 Lakh (FY 2025) | Active |
| Nurasyl Lifesciences Private Limited U51909GJ2019PTC110092 | Director | 01 Mar 2024 | 2019 | ₹15.1 Lakh (FY 2022) | Active |
Board colleagues of Tejas Ramesh Zaveri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Tejas Champaklal Shah | 01499314 | Dabilife Pharma Private Limited | Director |
| Jignasu Jaysukhbhai Sudani | 06464421 | Nurasyl Lifesciences Private Limited | Director |
| Maulikkumar Jaysukhbhai Sudani | 06464415 | Nurasyl Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tejas Ramesh Zaveri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tejas Ramesh Zaveri
Tejas Ramesh Zaveri currently holds 2 directorships: Dabilife Pharma Private Limited (Director, since 13 Feb 2024, revenue ₹38.4 Lakh (FY 2025)); Nurasyl Lifesciences Private Limited (Director, since 01 Mar 2024, revenue ₹15.1 Lakh (FY 2022)).
Tejas Ramesh Zaveri was first appointed on 13 Feb 2024 as Director at Dabilife Pharma Private Limited.
The 2 current companies of Tejas Ramesh Zaveri that report revenue have a combined latest revenue of ₹53.5 Lakh: Dabilife Pharma Private Limited ₹38.4 Lakh (FY 2025); Nurasyl Lifesciences Private Limited ₹15.1 Lakh (FY 2022).
The current boards of Tejas Ramesh Zaveri's companies include Tejas Champaklal Shah (Dabilife Pharma Private Limited), Jignasu Jaysukhbhai Sudani (Nurasyl Lifesciences Private Limited), Maulikkumar Jaysukhbhai Sudani (Nurasyl Lifesciences Private Limited).